ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
135 hedge funds and large institutions have $262M invested in iTeos Therapeutics in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 44 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $373M → $262M (-$111M)
33% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 40
72% less call options, than puts
Call options by funds: $5.88M | Put options by funds: $21.2M
Holders
135
Holding in Top 10
1
Calls
$5.88M
Puts
$21.2M
Top Buyers
| 1 | +$17.9M | |
| 2 | +$12.3M | |
| 3 | +$6.4M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$5.5M |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$3.92M |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$16.4M | |
| 3 | -$8.39M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$7.85M |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$5.46M |